Advertisement
Canada markets open in 16 minutes

  • S&P/TSX

    22,259.16
    -31.46 (-0.14%)
     

  • S&P 500

    5,187.67
    -0.03 (-0.00%)
     

  • DOW

    39,056.39
    +172.13 (+0.44%)
     

  • CAD/USD

    0.7290
    +0.0001 (+0.02%)
     

  • CRUDE OIL

    79.44
    +0.45 (+0.57%)
     

  • Bitcoin CAD

    84,307.65
    -628.45 (-0.74%)
     

  • CMC Crypto 200

    1,326.71
    +26.61 (+2.05%)
     

  • GOLD FUTURES

    2,333.00
    +10.70 (+0.46%)
     

  • RUSSELL 2000

    2,055.14
    -9.51 (-0.46%)
     

  • 10-Yr Bond

    4.4920
    0.0000 (0.00%)
     

  • NASDAQ futures

    18,193.75
    +7.25 (+0.04%)
     

  • VOLATILITY

    13.17
    +0.17 (+1.31%)
     

  • FTSE

    8,375.88
    +21.83 (+0.26%)
     

  • NIKKEI 225

    38,073.98
    -128.39 (-0.34%)
     

  • CAD/EUR

    0.6777
    +0.0001 (+0.01%)
     
MARKETS LIVE BLOG:

STOCK FUTURES TIP LOWER AS INVESTORS LOOK FOR INSPIRATION

Airbnb shares slump in premarket trading as gloomy Q2 forecasts fan slowdown fears

Cynosure (CYNO) in Focus: Stock Adds 17% in Session

Zacks Equity Research

Cynosure, Inc. (CYNO) was a big mover last session with its shares rising almost 17% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading above the volatile price range of $18.94 to $21.27 since July 7.

This developer of esthetic treatment systems primarily for the dermatology, plastic surgery and general medical markets has seen one negative estimate revision in the last 30 days. The Zacks Consensus Estimate has also moved lower over the same period. This implies trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s rally can last.

Cynosure currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Investors interested in the medical devices industry may consider better-ranked stocks like RTI Surgical Inc. (RTIX), Accuray Incorporated (ARAY) and Bacterin International Holdings, Inc. (BONE). While RTI Surgical and Accuray sport a Zacks Rank #1 (Strong Buy), Bacterin holds a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




CYNOSURE INC (CYNO): Free Stock Analysis Report

RTI SURGICAL INC (RTIX): Free Stock Analysis Report

ACCURAY (ARAY): Free Stock Analysis Report

BACTERIN INTERNATIONAL HOLDINGS (BONE): Free Stock Analysis Report


Zacks Investment Research